Gastrointestinal symptoms are associated with trajectories of chemotherapy-induced nausea | Zendy

Komal Singh | Zendy; Kord M. Kober | Zendy; Steven M. Paul | Zendy; Marilyn J. Hammer | Zendy; Fay Wright | Zendy; Yvette P. Conley | Zendy; Jon D. Levine | Zendy; Christine Miaskowski | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Gastrointestinal symptoms are associated with trajectories of chemotherapy-induced nausea

Author(s) -

Komal Singh,

Kord M. Kober,

Steven M. Paul,

Marilyn J. Hammer,

Fay Wright,

Yvette P. Conley,

Jon D. Levine,

Christine Miaskowski

Publication year - 2019

Publication title -

supportive care in cancer

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.133

H-Index - 112

eISSN - 1433-7339

pISSN - 0941-4355

DOI - 10.1007/s00520-019-05031-5

Subject(s) - medicine , nausea , vomiting , chemotherapy , constipation , etiology , gastroenterology , comorbidity , breast cancer , regimen , chemotherapy regimen , chemotherapy induced nausea and vomiting , cancer , antiemetic

Between 19 and 58% of oncology patients experience chemotherapy-induced nausea (CIN). In a sample of outpatients with breast, gastrointestinal (GI), gynecological, and lung cancer, the study purposes were to evaluate for inter-individual differences in the severity of CIN over two cycles of chemotherapy (CTX) and to determine which demographic and clinical characteristics and GI symptoms were associated with higher initial levels as well as with the trajectories of CIN severity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research